[Platelet serotonin in endogenous depressive patients and normal controls]

Area of Science:

• Neuroscience
• Biochemistry
• Psychiatry

Context:

• Depression is a complex mood disorder with heterogeneous clinical presentations.
• Platelet serotonin levels have been investigated as a potential biomarker for depression.
• Previous research suggests a link between endogenous depression and altered levels of phenylethylamine (PEA) and phenylacetic acid (PAA).

Purpose:

• To investigate platelet serotonin content in medication-free depressive patients and healthy controls.
• To determine if depressive patients can be subcategorized based on platelet serotonin levels.
• To explore the potential implications of these subgroups for treatment response.

Summary:

• This study analyzed platelet serotonin in 31 depressive patients and 29 controls, using urinary PEA and PAA levels for patient selection.
• Depressive patients were divided into two subgroups: one with significantly lower platelet serotonin (mean 407 +/- 102 ng/10^9 platelets) and another with levels similar to controls (mean 658 +/- 93 ng/10^9 platelets).
• Control group platelet serotonin levels ranged from 527-900 ng/10^9 platelets (mean 698 +/- 125 ng/10^9 platelets).

Impact:

• Findings suggest that platelet serotonin levels can differentiate subgroups within the depressive population.
• These subgroups may exhibit differential responses to serotonin reuptake blocker (SRB) treatments.
• This research opens avenues for personalized treatment strategies in depression based on biological markers.